☆ 4.7 Article

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

VACCINES (2021)

Related references

Note: Only part of the references are listed.

Review Virology

Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects

Arash Arashkia et al.

Summary: COVID-19 is caused by SARS-CoV-2 and an urgent need for the development of a safe and effective vaccine exists to prevent global spread. The spike (S) protein of SARS-CoV-2 plays a crucial role in cell entry and is a key target for vaccine development to induce protective immunity.

REVIEWS IN MEDICAL VIROLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine

Rafael Dal-Re et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Review Virology

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Ebenezer Tumban

Summary: SARS-CoV-2 candidate vaccines targeting the spike protein are showing promising results in phase I/II trials, with some already granted emergency use authorization. Expectations are high for phase III trials and recommendations for post-approval phase IV studies.

VIRUSES-BASEL (2021)

Add to Collection

Review Virology

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective

Colin D. Funk et al.

Summary: The SARS-CoV-2 virus has caused a devastating global pandemic with millions infected and dead. Efforts have been made to develop vaccines, with several in advanced stages of clinical trials and receiving emergency use authorization. The global vaccine rollout is crucial in ending the pandemic.

VIRUSES-BASEL (2021)

Add to Collection

Article Immunology

Acceptability of a COVID-19 Vaccine among the Saudi Population

Eman Ibrahim Alfageeh et al.

Summary: The study revealed that residents in the southern region, those who have received the seasonal influenza vaccine, believe in mandatory COVID-19 vaccination, and express high levels of concern about COVID-19 are more willing to get vaccinated. On the other hand, individuals with a history of vaccine refusal are less likely to have the intention to be vaccinated. There is a need for multifaceted interventions to target the low acceptance rate among the Saudi population, focusing on raising awareness and emphasizing the safety and efficacy of the COVID-19 vaccine.

VACCINES (2021)

Add to Collection

Article Infectious Diseases

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

Cristina Menni et al.

Summary: This study investigated the safety and effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines in a UK community setting. The results showed that the frequencies of side effects from these vaccines were lower than reported in clinical trials, and a significant reduction in the risk of SARS-CoV-2 infection was observed starting at 12 days after vaccination.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Immunology

A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective

Wedad Saeed Al-Qahtani et al.

Summary: SARS-CoV-2, also known as COVID-19, continues to be a global pandemic issue, prompting worldwide efforts in developing vaccines and disease control measures. Vaccination is currently seen as the most economically viable solution, though concerns about side effects and global health safety challenges exist. Scientists and companies globally are collaborating to research COVID-19, develop vaccines, and address potential risks from a global health safety perspective.

VACCINES (2021)

Add to Collection

Article Immunology

Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low-and Middle-Income Countries

Suzanna Awang Bono et al.

Summary: The global survey showed variations in vaccine acceptance rates among different countries, with education level and knowledge about the virus possibly influencing the acceptance rates. For those who consider vaccination as very important for themselves, the acceptance rate is higher.

VACCINES (2021)

Add to Collection

Article Medicine, General & Internal

Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study

Nagla A. El-Shitany et al.

Summary: This study tracked the short-term side effects of the Pfizer vaccine, finding common symptoms to include injection site pain, headaches, and fever. Females and individuals previously infected with the coronavirus were more likely to experience side effects.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience

Abdullah A. Algaissi et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Add to Collection

Review Biology

COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development

M. Sreepadmanabh et al.

JOURNAL OF BIOSCIENCES (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

Add to Collection

News Item Multidisciplinary Sciences

COVID VACCINES: WHAT SCIENTISTS NOW WANT TO KNOW

Heidi Ledford et al.

NATURE (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Vaccine hesitancy An overview

Eve Dube et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)

Add to Collection

Article Medicine, General & Internal

New Decade of Vaccines 5 Addressing the vaccine confidence gap

Heidi J. Larson et al.

LANCET (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.